Sequoia Financial Advisors LLC Has $3.50 Million Stock Position in Corteva, Inc. $CTVA

Sequoia Financial Advisors LLC raised its position in Corteva, Inc. (NYSE:CTVA) by 18.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,265 shares of the company’s stock after purchasing an additional 6,404 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Corteva were worth $3,495,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Parkside Financial Bank & Trust grew its stake in shares of Corteva by 3.2% in the 2nd quarter. Parkside Financial Bank & Trust now owns 3,729 shares of the company’s stock valued at $316,000 after buying an additional 116 shares in the last quarter. William B. Walkup & Associates Inc. raised its position in Corteva by 2.9% during the first quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock valued at $373,000 after acquiring an additional 126 shares in the last quarter. HB Wealth Management LLC lifted its stake in Corteva by 0.5% in the second quarter. HB Wealth Management LLC now owns 23,822 shares of the company’s stock valued at $2,018,000 after acquiring an additional 128 shares during the last quarter. Wilkerson Advisory Group LLC grew its position in Corteva by 6.7% in the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock worth $177,000 after acquiring an additional 133 shares in the last quarter. Finally, AdvisorNet Financial Inc grew its position in Corteva by 2.4% in the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock worth $477,000 after acquiring an additional 135 shares in the last quarter. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Trading Down 1.1%

NYSE:CTVA opened at $83.54 on Friday. The company’s 50 day moving average is $83.49 and its 200-day moving average is $81.33. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97. The firm has a market cap of $55.74 billion, a price-to-earnings ratio of 55.32, a P/E/G ratio of 2.58 and a beta of 0.57.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. During the same period in the prior year, the firm earned $2.20 EPS. Corteva’s quarterly revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio is 47.68%.

Key Stories Impacting Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Long-term earnings outlook is constructive: KeyCorp estimates Corteva will earn $4.00 per share in fiscal 2027 and $4.20 in fiscal 2028, above the current-year consensus estimate of $3.72. The forecasts suggest expected earnings growth following 2026, although the firm projects a seasonal loss of $0.33 per share in the third quarter and $0.31 of EPS in the fourth quarter.
• Positive Sentiment: New crop-protection venture: Corteva and Globachem plan to launch a joint venture focused on developing new crop-protection solutions. The partnership could expand Corteva’s product pipeline and support longer-term growth in agricultural inputs. Corteva, Globachem to Launch Joint Venture Focused on New Crop Protection Solutions
• Neutral Sentiment: KeyCorp begins coverage at “sector weight”: The rating is effectively neutral, indicating that KeyCorp does not expect Corteva to materially outperform or underperform its broader sector. The new coverage adds analyst visibility but does not provide a strong near-term catalyst.
• Negative Sentiment: PFAS settlement adds legal costs: Corteva, DuPont and Chemours agreed to pay $455 million to North Carolina and 11 local entities to resolve claims tied to PFAS contamination associated with the Fayetteville Works plant and other historical discharges. One law-firm release described the settlement as $380 million, suggesting differing descriptions of the agreement’s total components. The payment may pressure cash flow and keeps environmental liabilities in focus, although it removes uncertainty related to these specific claims. Chemours, DuPont, Corteva settle North Carolina forever chemicals claims

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the stock. Royal Bank Of Canada restated an “overweight” rating on shares of Corteva in a report on Friday, August 28th. Mizuho upped their price objective on shares of Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a report on Tuesday, July 14th. Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. JPMorgan Chase & Co. raised their target price on Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a report on Monday, August 3rd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $101.00 price target on shares of Corteva in a research report on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and a consensus target price of $91.50.

Corteva Profile

Corteva, Inc is a global agricultural science company that develops and supplies seed, crop protection and digital agriculture solutions. Its products are designed to help farmers improve crop productivity, manage pests and weeds, and address changing environmental and agricultural conditions.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crop varieties marketed under brands such as Pioneer and Brevant. Corteva also provides herbicides, insecticides, fungicides and biological products, including solutions associated with its Enlist weed-control system and other crop protection technologies.

Corteva serves farmers, agricultural retailers and other customers across North America, Latin America, Europe, Asia and other international markets.